Had you been taking Zantac (ranitidine) regularly prior to your cancer diagnosis?
Zantac is commonly taken to treat heartburn, indigestion and prevent ulcers in the intestines and stomach. Both Zantac and its generic, ranitidine, work to reduce the production of acid in the stomach which is often the cause of acid reflux and the resulting burning pain in the lower chest.
In September of 2019 the Food and Drug Administration (FDA) was informed that some batches of Zantac and Ranitidine contained a cancer causing carcinogen, N-Nitrosodimethylamine or NDMA. NDMA is a chemical found in petroleum-based substances such as gasoline.
On April 1, 2020 the FDA announced the recall of all ranitidine products and requested that all ranitidine products be removed from the shelves as a part of their ongoing investigation.
Frequent Zantac use over an extended period of time has been linked to the following cancers*:
If you took Zantac (ranitidine) frequently leading up to your cancer diagnosis, you may be entitled to compensation.
Locks Law Firm only provides legal advice after having entered into an attorney client relationship, which our website specifically does not create. Conversations that originate from website messaging, chat or other two way web based engagement do not create an attorney client relationship. It is imperative that any action taken be done on the advice of counsel. Because every case is different, the description of awards and cases previously handled do not guarantee a similar outcome in current or future cases. The firm practices law in Pennsylvania, New Jersey & New York as Locks Law Firm. Super Lawyers, Best Lawyers in America and other organizations that rate attorneys are not designations that have been approved by the State Supreme Courts or the American Bar Association.